Internal Medicine, Endocrinology, Diabetes, & Metabolism · Albuquerque, NM
NPI
1790933778
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8300 Constitution Ave NE
Albuquerque, NM, 87110
Phone (858) 345-0392
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
2,504 services
Medicare patients, 2024
1,176
Average age 74
Drug cost, 2024
$2.0M
6,768 prescriptions
Company payments, 2025
$725
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mansi B Mehta was code 77089 (standard x-ray), 715 times for 715 patients. In total Mansi B Mehta billed 2,504 services in 18 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77089 Standard X-ray | Facility | 715 | 715 | $24.26 | $17K |
| 77080 Standard X-ray | Facility | 702 | 702 | $9.01 | $6,326 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 273 | 246 | $11.51 | $3,142 |
| 99214 Office E&M - Established | Facility | 249 | 224 | $67.36 | $17K |
| 99215 Office E&M - Established | Facility | 151 | 118 | $100.41 | $15K |
| 95251 Test - Miscellaneous | Facility | 113 | 64 | $25.34 | $2,864 |
| 99204 Office E&M - New | Facility | 78 | 78 | $90.55 | $7,063 |
| 77081 Standard X-ray | Facility | 51 | 51 | $9.05 | $462 |
| 77092 Standard X-ray | Facility | 21 | 21 | $7.49 | $157 |
| 99205 Office E&M - New | Facility | 20 | 20 | $91.62 | $1,832 |
| 99214 Office E&M - Established | Office | 17 | 17 | $88.60 | $1,506 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $12.15 | $182 |
| 99406 Behavioral Health Services | Facility | 15 | 12 | $11.31 | $170 |
| 77080 Standard X-ray | Office | 14 | 13 | $4.71 | $65.94 |
| 77089 Standard X-ray | Office | 12 | 12 | $15.27 | $183 |
By year: 2022 $58K for 1,526 services; 2023 $65K for 1,864 services; 2024 $77K for 2,504 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mansi B Mehta prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,104 prescriptions and refills. In total Mansi B Mehta wrote 6,768 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,104 | 2,929 | 325 | $16K |
| Alendronate Sodium Generic | 275 | 698 | 79 | $3,881 |
| Lisinopril Generic | 243 | 597 | 68 | $2,692 |
| Metformin Hcl Er Metformin Hcl | 212 | 524 | 76 | $3,940 |
| Synthroid Levothyroxine Sodium | 189 | 487 | 53 | $16K |
| Atorvastatin Calcium Generic | 162 | 459 | 59 | $2,098 |
| Tresiba Flextouch U-100 Insulin Degludec | 150 | 280 | 41 | $114K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 144 | 292 | 69 | $18K |
| Metformin Hcl Generic | 137 | 408 | 47 | $1,671 |
| Methimazole Generic | 137 | 325 | 45 | $2,190 |
| Rosuvastatin Calcium Generic | 135 | 370 | 45 | $2,306 |
| Insulin Aspart Flexpen Insulin Aspart | 131 | 233 | 56 | $29K |
| Testosterone Cypionate Generic | 130 | 226 | 42 | $6,117 |
| Hydrochlorothiazide Generic | 109 | 295 | 35 | $1,218 |
| Losartan Potassium Generic | 109 | 314 | 37 | $1,473 |
Brand drugs: 2,893 claims; generic drugs: 3,400 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mansi B Mehta $725 ($725 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $150 |
| Insulet Corporation PODD | 5 | $126 |
| Novo Nordisk Inc NVO | 3 | $61 |
| Lilly USA, LLC LLY | 2 | $41.27 |
| Abbott Laboratories ABT | 2 | $34.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34.82 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $34.61 |
| Recordati_rare_diseases_inc. | 1 | $27.58 |
| Xeris Pharmaceuticals, Inc. | 1 | $22.59 |
| RGH Enterprises LLC | 1 | $22.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.